Publications

Publications
Publications 2025-05-08
Celea Therapeutics – Deupirfenidone (LYT-100)
Perspectives of people living with idiopathic pulmonary fibrosis: a qualitative and quantitative study
Publications 2025-02-11
Seaport
Molecular Pharmaceutics: Optimizing Triglyceride Prodrugs of a Model Immunomodulator: Conjugation through the Phenol of Mycophenolic Acid (MPA) Markedly Promotes Lymphatic Drug Transport
Publications 2024-03-04
Sonde
Validating the efficacy and value proposition of mental fitness vocal biomarkers in a psychiatric population: prospective cohort study
Publications 2023-04-15
Vedanta
VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection
Publications 2022-04-13
Vedanta
Cell Host & Microbe: Colonization of the live biotherapeutic product VE303 and modulation of the microbiota and metabolites in healthy volunteers
Publications 2022-04-12
Akili
American Journal of Psychiatry: Digital Intervention for Cognitive Deficits in Major Depression: A Randomized Controlled Trial to Assess Efficacy and Safety in Adults
Publications 2022-04-12
Frontiers in Pharmacology: Triglyceride-Mimetic Prodrugs of Buprenorphine Enhance Oral Bioavailability via Promotion of Lymphatic Transport
Publications 2021-12-31
Akili
PLOS ONE: Enhancing neural markers of attention in children with ADHD using a digital therapeutic
Publications 2021-11-15
Celea Therapeutics – Deupirfenidone (LYT-100)
Clinical Pharmacology in Drug Development: A randomized Phase 1 evaluation of deupirfenidone, a novel deuterium-containing drug candidate for interstitial lung disease and other inflammatory and fibrotic diseases
Publications 2021-11-01
Gelesis
Nature Scientific Reports: Biomimetic cellulose-based superabsorbent hydrogels for treating obesity

@PureTechH